UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Horizon Therapeutics (HZNP)

Horizon Therapeutics (HZNP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
116.30 +0.05 (+0.04%) 10/05/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 116.30 unch (unch) -
Quote Overview for Thu, Oct 5th, 2023
Day Low
116.26
Day High
116.38
Open 116.34
Previous Close 116.25 116.25
Volume 28,881,200 28,881,200
Avg Vol 3,994,490 3,994,490
Stochastic %K 95.81% 95.81%
Weighted Alpha +49.30 +49.30
5-Day Change +0.61 (+0.53%) +0.61 (+0.53%)
52-Week Range 60.03 - 116.38 60.03 - 116.38
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,632,118
  • Shares Outstanding, K 228,995
  • Annual Sales, $ 3,629 M
  • Annual Income, $ 521,480 K
  • EBIT $ 513 M
  • EBITDA $ 968 M
  • 60-Month Beta 1.03
  • Price/Sales 7.34
  • Price/Cash Flow 16.49
  • Price/Book 5.01
  • Price/Earnings ttm 25.89
  • Earnings Per Share ttm 4.49
  • Most Recent Earnings $1.20 on 08/08/23
  • Next Earnings Date 11/01/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate 1.22
  • Number of Estimates 4
  • High Estimate 1.46
  • Low Estimate 0.93
  • Prior Year 1.25
  • Growth Rate Est. (year over year) -2.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
114.75 +1.35%
on 09/11/23
Period Open: 115.51
116.38 -0.07%
on 10/05/23
+0.79 (+0.68%)
since 09/05/23
3-Month
98.80 +17.71%
on 08/03/23
Period Open: 102.97
116.38 -0.07%
on 10/05/23
+13.33 (+12.95%)
since 07/05/23
52-Week
60.03 +93.74%
on 10/13/22
Period Open: 67.05
116.38 -0.07%
on 10/05/23
+49.25 (+73.45%)
since 10/05/22

Most Recent Stories

More News
3 Growth Stocks to Buy in September

As the calendar turns to September, optimistic investors will look for value in quality companies with a history of generating strong revenue and earnings

AXP : 295.40 (-2.78%)
AMGN : 303.01 (+1.71%)
HZNP : 116.30 (+0.04%)
AAPL : 245.55 (-0.11%)
NFLX : 1,003.15 (-2.09%)
AMZN : 216.58 (-2.83%)
DIS : 108.66 (-1.71%)
AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION

/PRNewswire/ -- Amgen (NASDAQ:AMGN) and Horizon Therapeutics plc (NASDAQ:HZNP) today announced the entry into a consent order agreement with the Federal Trade...

AMGN : 303.01 (+1.71%)
HZNP : 116.30 (+0.04%)
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?

Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.

AMGN : 303.01 (+1.71%)
BMY : 55.83 (+0.07%)
LLY : 873.68 (+0.06%)
XLV : 146.43 (-0.54%)
HZNP : 116.30 (+0.04%)
JNJ : 162.30 (+1.64%)
MRK : 89.50 (+2.08%)
NVS : 109.35 (+1.90%)
NVO : 88.08 (+5.18%)
XPH : 44.71 (-0.49%)
ALPMY : 9.7300 (+0.62%)
Is This the Green Light Biotech Stocks Have Been Waiting For?

It looks like the Federal Trade Commission will give up on its attempt to block Amgen's acquisition of Horizon Therapeutics.

COMP : 8.98 (-8.18%)
AMGN : 303.01 (+1.71%)
HZNP : 116.30 (+0.04%)
Markets Today: Stock Climb and Bond Yields Fall as Interest Rate Concerns Ease

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.45%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.59%. Stock indexes this morning are moderately higher on some...

ESH25 : 6,029.00s (-1.75%)
NQH25 : 21,679.25s (-2.09%)
MMM : 144.98 (-2.75%)
HZNP : 116.30 (+0.04%)
ZBH : 104.83 (+1.16%)
BBIO : 36.85 (+0.12%)
HE : 10.76 (-1.91%)
RPT : 3.15 (-0.63%)
BSX : 104.49 (-0.83%)
APPF : 211.66 (-2.05%)
CRWD : 406.68 (-6.75%)
NVCR : 22.09 (+2.03%)
Is Amgen Stock a Top Buy and Hold?

The biotech checks several important boxes for long-term shareholders.

AMGN : 303.01 (+1.71%)
HZNP : 116.30 (+0.04%)
Could Amgen Stock Help You Become a Millionaire?

Its pending acquisition of Horizon Therapeutics could make the company much bigger.

AMGN : 303.01 (+1.71%)
HZNP : 116.30 (+0.04%)
Drinks, Chips & Drugs: A Surprising List of 10-Year Stock Winners

A handful of large caps have taken things to another level. These three stocks have blown past the herd — and may be market leaders for years to come.

CELH : 32.62 (+27.77%)
NVDA : 134.43 (-4.05%)
HZNP : 116.30 (+0.04%)
AAPL : 245.55 (-0.11%)
TSLA : 337.80 (-4.68%)
AMZN : 216.58 (-2.83%)
MNST : 53.00 (+3.50%)
PEP : 153.50 (+2.95%)
AMD : 110.84 (-2.92%)
MSFT : 408.21 (-1.90%)
GOOGL : 179.66 (-2.65%)
LLY : 873.68 (+0.06%)
Markets Today: Stocks Tumble as Moody’s Cuts Ratings on Regional Banks

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.65%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.61%. Stock indexes this morning are moderately lower. Weakness...

ESH25 : 6,029.00s (-1.75%)
NQH25 : 21,679.25s (-2.09%)
CFG : 44.88 (-2.82%)
FITB : 42.88 (-1.67%)
HBAN : 16.15 (-1.64%)
LNC : 37.55 (-3.15%)
MTB : 193.53 (-1.99%)
NTRS : 112.97 (-0.49%)
PNC : 188.05 (-2.00%)
RF : 23.39 (-2.78%)
TFC : 45.66 (-2.12%)
USB : 45.87 (-1.90%)
Is Growth Priced into Amgen Stock after Earnings Beat?

Amgen earnings delivered a solid earnings report after the market closed but analyst sentiment suggests that growth may already be priced into AMGN stock.

AMGN : 303.01 (+1.71%)
ABBV : 202.08 (+0.60%)
HZNP : 116.30 (+0.04%)
Hogs Fall Again on Thursday

Lean hogs rounded out Thursday with more pressure, as contracts were down $1.17 to $1.37. The USDA’s national average base hog negotiated price was reported at $89.44, down $2.54 from the day prior....

HEJ25 : 87.675s (-0.96%)
HEK25 : 91.950s (-0.54%)
HEM25 : 100.625s (+0.32%)
Cattle Face Pressure on Thursday

Live cattle futures closed out the Thursday session with loses of 20 cents to $1. Cash trade has been slower this week, kicking on with light action at $199 in the South and $315 dressed in the North....

LEM25 : 190.325s (+0.18%)
LEG25 : 197.825s (+0.10%)
LEJ25 : 193.950s (+0.08%)
GFH25 : 267.950s (+0.42%)
GFJ25 : 267.550s (+0.44%)
GFK25 : 265.925s (+0.32%)
Poor results from cutting slaughter pace

With great expectations of stabilizing, if not increasing box prices, through dramatic slaughter cuts, the packer has made his move.  These dramatic cuts are believed to have negated the foretelling of...

Livestock Slaughter

Livestock Slaughter - 2025-02-20

YKK25 : 13,020s (-0.04%)
HEJ25 : 87.675s (-0.96%)
GFJ25 : 267.550s (+0.44%)
LEJ25 : 193.950s (+0.08%)
Levels to Watch into the Weekend for Grain and Livestock Markets

Grain and livestock markets have presented some great tradable opportunities for participants on both sides of the markets as of late. These are the levels to keep an eye on.

Cattle Falling on Thursday

Live cattle futures are trading with contracts down 62 cent to $1.52 at midday. Cash trade has been slower this week, with bids so far at $198 in the South and $200 in the North. The Thursday morning Central...

LEM25 : 190.325s (+0.18%)
LEG25 : 197.825s (+0.10%)
LEJ25 : 193.950s (+0.08%)
GFH25 : 267.950s (+0.42%)
GFJ25 : 267.550s (+0.44%)
GFK25 : 265.925s (+0.32%)
Hogs Continuing Slide on Thursday

Lean hogs are trading with another round of weakness, with losses of $1.15 to $1.25. Thursday morning’s national average base hog negotiated price was reported at $89.45 by the USDA, down $3.32 from...

HEJ25 : 87.675s (-0.96%)
HEK25 : 91.950s (-0.54%)
HEM25 : 100.625s (+0.32%)
Cattle Shift Focus to Thursday Trade

Live cattle futures settled the Wednesday session with 35 to 75 cent gains. Cash trade has been slower this week, with last week’s trade mainly $202-203 in the South and $203 in the North. Wednesday...

LEM25 : 190.325s (+0.18%)
LEG25 : 197.825s (+0.10%)
LEJ25 : 193.950s (+0.08%)
GFH25 : 267.950s (+0.42%)
GFJ25 : 267.550s (+0.44%)
GFK25 : 265.925s (+0.32%)
Hogs Fall Lower on Wednesday

Lean hog futures were pressured by a weaker cutout on Wednesday with losses of $3.25 to $3.60. Much of that was likely to long liquidation, with preliminary open interest down 9,466 contracts The Wednesday...

HEJ25 : 87.675s (-0.96%)
HEK25 : 91.950s (-0.54%)
HEM25 : 100.625s (+0.32%)
Cattle Post Mixed Trade on Wednesday

Live cattle futures closed Wednesday with 35 to 75 cent gains at the close. Cash trade has yet to kick off this week, with last week’s trade mainly $202-203 in the South and $203 in the North. The Wednesday...

LEM25 : 190.325s (+0.18%)
LEG25 : 197.825s (+0.10%)
LEJ25 : 193.950s (+0.08%)
GFH25 : 267.950s (+0.42%)
GFJ25 : 267.550s (+0.44%)
GFK25 : 265.925s (+0.32%)
Hogs Fall Again on Thursday

Lean hogs rounded out Thursday with more pressure, as contracts were down $1.17 to $1.37. The USDA’s national average base hog negotiated price was reported at $89.44, down $2.54 from the day prior....

HEJ25 : 87.675s (-0.96%)
HEK25 : 91.950s (-0.54%)
HEM25 : 100.625s (+0.32%)
Cattle Face Pressure on Thursday

Live cattle futures closed out the Thursday session with loses of 20 cents to $1. Cash trade has been slower this week, kicking on with light action at $199 in the South and $315 dressed in the North....

LEM25 : 190.325s (+0.18%)
LEG25 : 197.825s (+0.10%)
LEJ25 : 193.950s (+0.08%)
GFH25 : 267.950s (+0.42%)
GFJ25 : 267.550s (+0.44%)
GFK25 : 265.925s (+0.32%)
Poor results from cutting slaughter pace

With great expectations of stabilizing, if not increasing box prices, through dramatic slaughter cuts, the packer has made his move.  These dramatic cuts are believed to have negated the foretelling of...

Livestock Slaughter

Livestock Slaughter - 2025-02-20

YKK25 : 13,020s (-0.04%)
HEJ25 : 87.675s (-0.96%)
GFJ25 : 267.550s (+0.44%)
LEJ25 : 193.950s (+0.08%)
Levels to Watch into the Weekend for Grain and Livestock Markets

Grain and livestock markets have presented some great tradable opportunities for participants on both sides of the markets as of late. These are the levels to keep an eye on.

Cattle Falling on Thursday

Live cattle futures are trading with contracts down 62 cent to $1.52 at midday. Cash trade has been slower this week, with bids so far at $198 in the South and $200 in the North. The Thursday morning Central...

LEM25 : 190.325s (+0.18%)
LEG25 : 197.825s (+0.10%)
LEJ25 : 193.950s (+0.08%)
GFH25 : 267.950s (+0.42%)
GFJ25 : 267.550s (+0.44%)
GFK25 : 265.925s (+0.32%)
Hogs Continuing Slide on Thursday

Lean hogs are trading with another round of weakness, with losses of $1.15 to $1.25. Thursday morning’s national average base hog negotiated price was reported at $89.45 by the USDA, down $3.32 from...

HEJ25 : 87.675s (-0.96%)
HEK25 : 91.950s (-0.54%)
HEM25 : 100.625s (+0.32%)
Cattle Shift Focus to Thursday Trade

Live cattle futures settled the Wednesday session with 35 to 75 cent gains. Cash trade has been slower this week, with last week’s trade mainly $202-203 in the South and $203 in the North. Wednesday...

LEM25 : 190.325s (+0.18%)
LEG25 : 197.825s (+0.10%)
LEJ25 : 193.950s (+0.08%)
GFH25 : 267.950s (+0.42%)
GFJ25 : 267.550s (+0.44%)
GFK25 : 265.925s (+0.32%)
Hogs Fall Lower on Wednesday

Lean hog futures were pressured by a weaker cutout on Wednesday with losses of $3.25 to $3.60. Much of that was likely to long liquidation, with preliminary open interest down 9,466 contracts The Wednesday...

HEJ25 : 87.675s (-0.96%)
HEK25 : 91.950s (-0.54%)
HEM25 : 100.625s (+0.32%)
Cattle Post Mixed Trade on Wednesday

Live cattle futures closed Wednesday with 35 to 75 cent gains at the close. Cash trade has yet to kick off this week, with last week’s trade mainly $202-203 in the South and $203 in the North. The Wednesday...

LEM25 : 190.325s (+0.18%)
LEG25 : 197.825s (+0.10%)
LEJ25 : 193.950s (+0.08%)
GFH25 : 267.950s (+0.42%)
GFJ25 : 267.550s (+0.44%)
GFK25 : 265.925s (+0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Horizon Therapeutics plc is a biopharmaceutical focused on making drugs in arthritis, pain, inflammatory and orphan diseases areas.

See More

Key Turning Points

3rd Resistance Point 116.49
2nd Resistance Point 116.43
1st Resistance Point 116.37
Last Price 116.30
1st Support Level 116.25
2nd Support Level 116.19
3rd Support Level 116.13

See More

52-Week High 116.38
Last Price 116.30
Fibonacci 61.8% 94.85
Fibonacci 50% 88.21
Fibonacci 38.2% 81.56
52-Week Low 60.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements